ClinicalTrials.gov · NCT07322224 · Completed
Multi-Modal Longevity Protocol Including Autologous Cell-Free Conditioned Media
Registry record
NCT07322224 on ClinicalTrials.gov. The registry's last update to this record was 7 January 2026.
Verification record
5 checked · 0 company says · 0 reported · 0 not found · 0 not yet checked
- Title as registered Multi-Modal Longevity Protocol Including Autologous Cell-Free Conditioned Media Checked Source clinicaltrials.gov Brief title as registered. Checked
- Sponsor BlueBird Age Reversal SA Checked Source clinicaltrials.gov Lead sponsor as registered. Checked
- Intervention Multi-Modal Longevity Protocol Checked Source clinicaltrials.gov Intervention names as registered. Checked
- Primary outcome as registered Change in Epigenetic Biological Age Checked Source clinicaltrials.gov Primary outcome measure(s) as registered. Checked
- Status Completed Checked Source clinicaltrials.gov Overall status as registered; registry last update 2026-01-07. Checked
Check history: NCT07322224 was last read on the registry on November 14, 2026. No earlier checks are recorded. How records are checked.
Corrections: none recorded for this trial. To ask for one, write to [email protected] with the registry number; every correction is checked against the registry record before the record changes.
As registered
- Sponsor: BlueBird Age Reversal SA
- Phase: Not applicable
- Status: Completed
- Intervention: Multi-Modal Longevity Protocol
- Primary outcome: Change in Epigenetic Biological Age
- Countries: United Kingdom
- Start: 5 August 2024
- Completion (actual): 20 March 2025
Results
No results were posted on the registry on the date checked. The Atlas does not summarize findings.